Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Inhibition of the RNA translation factor, eIF4E, as a novel treatment strategy in Ewing Sarcoma
Dr. John Prensner, M.D., Ph.D. – The Regents of the University of Michigan, Ann Arbor, MI
Dissecting Ewing Sarcoma On-Chip for Better Therapeutics
Dissecting Ewing Sarcoma On-Chip for Better Therapeutics
Dr. Yuan Gao, Ph.D. – Case Western Reserve University - School of Medicine, Cleveland, OH
Targeting ATR/SPOP Signaling to Overcome Chemotherapy Resistance in Ewing Sarcoma
Targeting ATR/SPOP Signaling to Overcome Chemotherapy Resistance in Ewing Sarcoma
The University of North Carolina at Chapel Hill, Chapel Hill, NC
Targeting RNA Processing Defects of Ewing Sarcoma
Targeting RNA Processing Defects of Ewing Sarcoma
UT Health Science Center at San Antonio, San Antonio, TX
‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients
‘Eyes Absent’ Gene Investigation in Ewing’s Sarcoma Patients
Cincinnati Children’s Hospital, Cincinnati, OH
Phase II Ewing’s Sarcoma Clinical Trial
Phase II Ewing’s Sarcoma Clinical Trial
Nemours/A.I. DuPont Hospital, Wilmington, DE